Carbonic Anhydrase Inhibitor [EPC]

20245 reported adverse events

Drugs of this class: ACETAZOLAMIDE BRINZOLAMIDE DICHLORPHENAMIDE ACETAZOLAMIDE EXTENDED-RELEASE BRINZOLAMIDE/BRIMONIDINE TARTRATE

These side effects are most commonly reported by patients taking drugs of the Carbonic Anhydrase Inhibitor [EPC] class:

# Side effect Count
0 TREATMENT FAILURE 1812
1 DRUG INEFFECTIVE 1560
2 OFF LABEL USE 1166
3 FATIGUE 1129
4 DYSPNOEA 1013
5 DIZZINESS 969
6 HEADACHE 946
7 NAUSEA 830
8 EYE PAIN 809
9 VISION BLURRED 809
See all common reactions for Carbonic Anhydrase Inhibitor [EPC]

Drugs of the Carbonic Anhydrase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 231 0.2145
1 CHOROIDAL DETACHMENT 72 0.1297
2 CHOROIDAL EFFUSION 91 0.1133
3 INTRAOCULAR PRESSURE DECREASED 59 0.1120
4 EYE ALLERGY 125 0.0806
5 INTRAOCULAR PRESSURE INCREASED 631 0.0493
6 URINARY TRACT DISORDER 200 0.0444
7 ANGLE CLOSURE GLAUCOMA 108 0.0423
8 CONJUNCTIVITIS ALLERGIC 59 0.0398
9 CORNEAL OEDEMA 85 0.0379
See all enriched reactions for Carbonic Anhydrase Inhibitor [EPC]